申请人:KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
公开号:US20180057527A1
公开(公告)日:2018-03-01
The present invention relates to a carbazole compound having anti-virus activity, and more particularly, to a novel compound selected from the group of consisting of a carbazole compound which shows excellent anti-proliferative efficacy against hepatitis C virus (HCV), a pharmaceutically acceptable salt thereof, a hydrate thereof, and an isomer thereof; an anti-virus pharmaceutical composition including the novel compound as an active ingredient; a pharmaceutical composition for preventing or treating liver diseases caused by hepatitis C virus; and a method of preparing the novel compound.
本发明涉及一种具有抗病毒活性的咔唑化合物,更具体地说,涉及一种从咔唑化合物组中选择的新化合物,该化合物对丙型肝炎病毒(HCV)表现出优异的抗增殖功效,其药用盐、水合物和异构体;包括该新化合物作为活性成分的抗病毒药物组合物;用于预防或治疗由丙型肝炎病毒引起的肝病的药物组合物;以及制备该新化合物的方法。